Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topics
- Shortages and supply disruptions (18)
- Safety monitoring and information (10)
- Manufacturing (7)
- Compliance and enforcement (6)
- Labelling and packaging (4)
- Import and export (3)
- Scheduling (national classification system) (3)
- Committees and advisory bodies (2)
- Legislation (2)
- Advertising (1)
- Clinical trials (1)
- Fees and payments (1)
- Medicinal cannabis hub (1)
- Weight loss products (1)
Collection content
111 result(s) found, displaying 31 to 40
-
GuidanceAustralian recommendations and requirements
-
GuidanceGuidance about how to make variations to Australian Register of Therapeutic Goods (ARTG) entries for prescription medicines.
-
GuidanceGuidance about the types of notifications and variations for biological medicines.
-
GuidanceGuidance about the types of notifications and variations for chemically derived (non-biological) prescription medicines.
-
GuidanceGuidance about application pathways and data requirements for new generic medicines, and variations to existing medicines.
-
GuidanceGuidance to understand the quality requirements of Therapeutic Goods Order No. 101 - Standard for tablets, capsules and pills (TGO 101, the Order).
-
GuidanceGuidance for sponsors about how to apply for orphan drug designation for a prescription medicine.
-
GuidanceGuidance on submitting the CPD for prescription medicines.
-
GuidanceGuidance on specific criteria and paperwork required for submission to the TGA to ensure conformance with TGO 93.
-
GuidanceGuidance on how to prepare your application for orphan drug designation so that it meets eligibility criteria and requirements.